Biblio

Author Title [ Type(Desc)] Year
Filters: Author is Elhaddad, Alaa  [Clear All Filters]
Journal Article
Tokaz MC, Baldomero H, Cowan AJ, Saber W, Greinix H, Koh MBc, Kröger N, Mohty M, Galeano S, Okamoto S, et al. An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Transplant Cell Ther. 2022.
Elborai Y, Hafez H, Moussa EA, Hammad M, Hussein H, Lehmann L, Elhaddad A. Comparison of toxicity following different conditioning regimens (busulfan/melphalan and carboplatin/etoposide/melphalan) for advanced stage neuroblastoma: Experience of two transplant centers. Pediatr Transplant. 2015.
Mohammed J, Aljurf M, Althumayri A, Almansour M, Alghamdi A, Hamidieh AAli, Elhaddad A, Ben Othman T, Bazarbachi A, Almohareb F, et al. Physical therapy pathway and protocol for patients undergoing hematopoietic stem cell transplantation: Recommendations from The Eastern Mediterranean Blood and Marrow Transplantation (EMBMT) Group. Hematol Oncol Stem Cell Ther. 2019.
Abdallah AM, Hafez H, Madney Y, Ahmed S, Yassin D, Salem S, Yousry R, Abdel-Azim H, Lehmann L, Elhaddad A. Predictive value of early molecular response to tyrosine kinase inhibitors in pediatric patients with chronic myeloid leukemia. Leuk Lymphoma. 2024:1-4.
Hafez HAhmed, Yousif D, Abbassi M, Elborai Y, Elhaddad A. Prophylactic Levofloxacin in Pediatric Neutropenic Patients during Autologous Hematopoietic Stem Cell Transplantation. Clin Transplant. 2015.
Hashmi S, Shaheen M, Adil S, Ahmed P, Ahmed S, Abdeljelil B, Alabdulwahab A, Albeihany A, Aldaama S, Al-Khabori M, et al. Unique aspects of Graft-versus-host-disease management in the Eastern Mediterranean region: Report from the Eastern Mediterranean blood and marrow transplantation group: Special report. Hematol Oncol Stem Cell Ther. 2020.
Hashmi S, Shaheen M, Adil S, Ahmed P, Ahmed S, Ben Abdeljelil N, Alabdulwahab A, Albeihany A, Aldaama S, Al-Khabori M, et al. Unique aspects of Graft-versus-host-disease management in the Eastern Mediterranean region: Report from the Eastern Mediterranean blood and marrow transplantation group: Special report. Hematol Oncol Stem Cell Ther. 2023;16(4):303-306.